Sign In
Buy IVW
$134.69
+0.430 (+0.320%)
At Close: Jul 20, 2026
IVW: Big Tech Sidelining Only Transitory
01:20pm, Tuesday, 08'th Jun 2021
Growth's prolific interest-rate beat down has been a central theme of US equity markets H1, 2021. It has impacted large-cap US-listed growth firms too, with broad representation across multiple asset
New Edge Capital's Rob Sechan on the growth-versus-value debate
01:04pm, Tuesday, 08'th Jun 2021
Rob Sechan, co-founder and managing partner of New Edge Capital Group, joins CNBC's "Halftime Report" to discuss the growth versus value trade.
PRNT: ETF For The Future With Mixed Short-Term Prospects
02:49pm, Tuesday, 25'th May 2021
PRNT: ETF For The Future With Mixed Short-Term Prospects
At the close of Refinitiv Lipper's fund-flows week, U.S. broad-based indices each logged their worst-performing week in more than five weeks. While the corporate earnings season may be slowing down, m
How these investors are watching the growth trade
01:13pm, Friday, 16'th Apr 2021
CNBC's "Halftime Report" team discusses investment strategies amid the market action. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNB
Value is finally outpacing growth this year but will still falter long term, traders say
05:42pm, Thursday, 11'th Mar 2021
The growth vs. value debate rolls on as value stocks attempt yet another comeback.
A Bunch of Top-Ranked Growth ETFs Hitting New Highs (Revised)
10:37am, Friday, 12'th Feb 2021
Growth ETFs seem having more upside potential in the coming months, given a surging stock market and improving prospect of economic growth.
A Bunch of Top-Ranked Growth ETFs Hitting New Highs
11:22am, Tuesday, 09'th Feb 2021
Growth ETFs seem having more upside potential in the coming months, given a surging stock market and improving prospect of economic growth.
5 Growth ETFs to Gain on Stimulus & Vaccine Optimism
03:48pm, Friday, 22'nd Jan 2021
It is being believed that the chances of another trench of coronavirus-aid package and improved coronavirus vaccine rollout are making a strong case in favor of faster U.S. economic recovery in 2021.
How investors can approach the growth-versus-value debate in 2021
03:55pm, Wednesday, 30'th Dec 2020
Nancy Prial, Essex Investment Management, and David Katz, chief investment officer at Matrix Advisors, join "The Exchange" to discuss how investors can best play the growth versus value trade. For acc
IVW: Growth Stocks Risk Being Victims Of Their Own Success
07:35am, Monday, 07'th Dec 2020
Investors have bid up U.S. growth stocks to valuations levels that require an extrapolation of the rapid earnings growth seen over the past decade. Revenue growth is likely to slow sharply as a result
Tech to grow slower than other sectors in 2021: Veritas' Greg Branch
02:49pm, Monday, 16'th Nov 2020
Greg Branch, managing partner at Veritas Financial Group, and Larry Adam, CIO at Raymond James, join "Power Lunch" to discuss the markets and the rotation into sectors outside stay-at-home stocks.
The Week The Market Rally's Lack Of Breadth Caught Up To The S&P 500
01:34pm, Tuesday, 08'th Sep 2020
Over the last several weeks, the S&P 500 has been on a tear, setting records on an almost daily basis despite lacking breadth, with the biggest rises in stock prices concentrated in the technology sec
The Perils Of Passive Investing Amid A Highly Concentrated S&P 500
08:11am, Sunday, 06'th Sep 2020
Five companies now comprise 26% of the market capitalization of the S&P 500® Index, making for the most concentrated U.S. equity market in the last 40 years.
Growth And Momentum Equity Factors Pull Further Ahead
08:03am, Friday, 04'th Sep 2020
The leading performances for the growth and momentum buckets in the US stock market continue to pull ahead, based on a set of exchange-traded funds.
